Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Brawanski

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
World Neurosurgery|September 23, 2017
Fluorescein-Guided Resection of Intramedullary Spinal Cord Tumors: Results from a Preliminary, Multicentric, Retrospective StudyFrancesco Acerbi, Claudio Cavallo, Karl-Michael Schebesch, et al.
Plos One|October 1, 2014
Response-predictive gene expression profiling of glioma progenitor cells in vitroSylvia Moeckel, Katharina Meyer, Petra Leukel, et al.
Frontiers in Oncology|April 21, 2022
Breakouts-A Radiological Sign of Poor Prognosis in Patients With Brain MetastasesRaquel Blazquez, Martin Andreas Proescholdt, Marlene Klauser, et al.
Cancer Research|July 18, 2008
Temozolomide preferentially depletes cancer stem cells in glioblastomaDagmar Beier, Stefanie Röhrl, Deepu R Pillai, et al.
Cancer|December 12, 2003
Salvage therapy in patients with glioblastoma: is there any benefit?Peter Hau, Ulrike Baumgart, Katharina Pfeifer, et al.
Cancer|March 17, 2004
Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade gliomaPeter Hau, Klaus Fabel, Ulrike Baumgart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2017
Fluorescein-Guided Surgery for Resection of High-Grade Gliomas: A Multicentric Prospective Phase II Study (FLUOGLIO)Francesco Acerbi, Morgan Broggi, Karl-Michael Schebesch, et al.
BMC Cancer|September 4, 2009
RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II studyChristoph P Beier, Christina Schmid, Thierry Gorlia, et al.
Neuro-Oncology Advances|January 23, 2023
NS-HGlio: A generalizable and repeatable HGG segmentation and volumetric measurement AI algorithm for the longitudinal MRI assessment to inform RANO in trials and clinicsAly H Abayazeed, Ahmed Abbassy, Michael Müeller, et al.
Oligonucleotides|July 20, 2007
Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studiesPeter Hau, Piotr Jachimczak, Reimar Schlingensiepen, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
World Neurosurgery|September 23, 2017
Fluorescein-Guided Resection of Intramedullary Spinal Cord Tumors: Results from a Preliminary, Multicentric, Retrospective StudyFrancesco Acerbi, Claudio Cavallo, Karl-Michael Schebesch, et al.
Plos One|October 1, 2014
Response-predictive gene expression profiling of glioma progenitor cells in vitroSylvia Moeckel, Katharina Meyer, Petra Leukel, et al.
Frontiers in Oncology|April 21, 2022
Breakouts-A Radiological Sign of Poor Prognosis in Patients With Brain MetastasesRaquel Blazquez, Martin Andreas Proescholdt, Marlene Klauser, et al.
Cancer Research|July 18, 2008
Temozolomide preferentially depletes cancer stem cells in glioblastomaDagmar Beier, Stefanie Röhrl, Deepu R Pillai, et al.
Cancer|December 12, 2003
Salvage therapy in patients with glioblastoma: is there any benefit?Peter Hau, Ulrike Baumgart, Katharina Pfeifer, et al.
Cancer|March 17, 2004
Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade gliomaPeter Hau, Klaus Fabel, Ulrike Baumgart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2017
Fluorescein-Guided Surgery for Resection of High-Grade Gliomas: A Multicentric Prospective Phase II Study (FLUOGLIO)Francesco Acerbi, Morgan Broggi, Karl-Michael Schebesch, et al.
BMC Cancer|September 4, 2009
RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II studyChristoph P Beier, Christina Schmid, Thierry Gorlia, et al.
Neuro-Oncology Advances|January 23, 2023
NS-HGlio: A generalizable and repeatable HGG segmentation and volumetric measurement AI algorithm for the longitudinal MRI assessment to inform RANO in trials and clinicsAly H Abayazeed, Ahmed Abbassy, Michael Müeller, et al.
Oligonucleotides|July 20, 2007
Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studiesPeter Hau, Piotr Jachimczak, Reimar Schlingensiepen, et al.
Pageof 14